1,228
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Successful management of pyoderma gangrenosum after caesarean section: a case report

, , , &
Article: 2289546 | Received 01 Oct 2022, Accepted 24 Nov 2023, Published online: 27 Dec 2023

References

  • Alavi, A., et al., 2017. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. American Journal of Clinical Dermatology, 18 (3), 355–372.
  • Carter, H., et al., 2021. Comparison of three diagnostic frameworks for pyoderma gangrenosum. Journal of Investigative Dermatology, 141, 59–63.
  • Croia, C., et al., 2021. Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum. Experimental Dermatology, 30 (9), 1340–1344.
  • Defilippis, E.M., Feldman, S.R. and Huang, W.W., 2015. The genetics of pyoderma gangrenosum and implications for treatment: a systematic review. The British Journal of Dermatology, 172 (6), 1487–1497.
  • George, C., Deroide, F. and Rustin, M., 2019. Pyoderma gangrenosum – a guide to diagnosis and management. Clinical Medicine, 19 (3), 224–228.
  • Inversetti, A., et al., 2023. Endometrial microbiota and immune tolerance in pregnancy. International Journal of Molecular Sciences, 24 (3), 2995.
  • Ishikawa, M. and Yamamoto, T., 2023. Neutrophil extracellular traps formation in the lesional skin of various types of pyoderma gangrenosum. Experimental Dermatology, 32 (11), 2029–2033.
  • Manda-Handzlik, A., et al., 2020. Nitric oxide and peroxynitrite trigger and enhance release of neutrophil extracellular traps. Cellular and Molecular Life Sciences, 77 (15), 3059–3075.
  • Maronese, C.A., et al., 2022. Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. American Journal of Clinical Dermatology, 23 (5), 615–634.
  • Ogawa, Y., et al., 2021. Neutrophil extracellular traps in skin diseases. Biomedicines, 9 (12), 1888.
  • Papayannopoulos, V. and Zychlinsky, A., 2009. NETs: a new strategy for using old weapons. Trends in Immunology, 30 (11), 513–521.
  • Ramos, B.D.A., et al., 2015. Microorganisms in the female genital tract during pregnancy: tolerance versus pathogenesis. American Journal of Reproductive Immunology, 73 (5), 383–389.
  • Sasor, S.E., et al., 2018. Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases. Journal of Wound Care, 27 (Sup1), S4–S8.
  • Simman, R., et al., 2021. An unusual presentation of blastomycosis-like pyoderma gangrenosum. Wounds, 33 (8), 203–206.
  • Stuebe, A.M., et al., 2012. Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology, 207 (1), 62.e1–62.e7.
  • Tuffaha, S.H., et al., 2016. Pyoderma gangrenosum after breast surgery: diagnostic pearls and treatment recommendations based on a systematic literature review. Annals of Plastic Surgery, 77 (2), e39–e44.
  • Wollina, U. and Haroske, G., 2011. Pyoderma gangraenosum. Current Opinion in Rheumatology, 23 (1), 50–56.
  • Yamamoto, T., et al., 2023. Clinical guidance of pyoderma gangrenosum. The Journal of Dermatology, 50 (9), e253–e275.